Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > As votes are cast and tallied let's work on a 2022 agenda

<< Previous

Bullboard Posts

Next >>

Post by Sciotoon May 10, 2021 10:11am

224 Views

Post# 33164311

As votes are cast and tallied let's work on a 2022 agenda

We all have a common interest to enhance shareholder value. After a bitter sweet year and horrible OO, we became divided on the BOD vote. As the votes are tallied, let's do are best to look forward and develop a common agenda that we can pledge to and promote and press with management, and be resolved to stand together on it and use our shares and votes to enhance shareholder value.

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta